A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer

被引：0
|
作者：
Abratt, RP
Bezwoda, WR
Goedhals, L
Hacking, DJ
机构：
[1] UNIV CAPE TOWN,RONDEBOSCH 7700,SOUTH AFRICA
[2] UNIV WITWATERSRAND,JOHANNESBURG 2050,SOUTH AFRICA
[3] UNIV ORANGE FREE STATE,BLOEMFONTEIN 9301,SOUTH AFRICA
[4] DURBAN ONCOL CTR,DURBAN,SOUTH AFRICA
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1086 / 1086
页数：1
相关论文
共 50 条
  • [21] Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling
    Huisman, C
    Giaccone, G
    van Groeningen, CJ
    Sutedja, G
    Postmus, PE
    Smit, EF
    LUNG CANCER, 2001, 33 (2-3) : 267 - 275
  • [22] Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study
    Niho, S
    Kubota, K
    Goto, K
    Ohmatsu, H
    Matsumoto, T
    Kakinuma, R
    Nishiwaki, Y
    BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1360 - 1364
  • [23] Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: A phase II study
    Aydiner, Adnan
    Kiyik, Murat
    Cikrikcioglu, Saadettin
    Kosar, Filiz
    Gurses, Atilla
    Turna, Akif
    Yazar, Aziz
    Dilege, Sukru
    Goksel, Tuncay
    Cakan, Alpaslan
    LUNG CANCER, 2007, 58 (02) : 246 - 252
  • [24] Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer
    Kaira, K
    Takise, A
    Minato, K
    Iwasaki, Y
    Ishihara, S
    Takei, Y
    Tsuchiya, S
    Saito, R
    Sato, K
    Mori, M
    ANTI-CANCER DRUGS, 2005, 16 (04) : 455 - 460
  • [25] Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Mazzanti, P
    Massacesi, C
    Rocchi, MBL
    Mattioli, R
    Lippe, P
    Trivisonne, R
    Buzzi, F
    De Signoribus, G
    Tuveri, G
    Rossi, G
    Di Lullo, L
    Sturba, F
    Morale, D
    Catanzani, S
    Pilone, A
    Bonsignori, M
    Battelli, T
    LUNG CANCER, 2003, 41 (01) : 81 - 89
  • [26] A phase II of gemcitabine in advanced non-small cell lung cancer
    Koynov, K
    Tzekova, V
    Mincheva, N
    Scherer, A
    Krejcy, K
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 231 - 234
  • [27] Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: A Hoosier oncology group study
    Einhorn, LH
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 824 - 826
  • [28] A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer
    Pallis, AG
    Agelidou, A
    Papakotoulas, P
    Tsaroucha, A
    Agelidou, M
    Agelaki, S
    Androulakis, N
    Vamvakas, L
    Gerogianni, A
    Kotsakis, A
    Kentepozidis, N
    Georgoulias, V
    LUNG CANCER, 2006, 52 (02) : 165 - 171
  • [29] A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life
    Jassem, J
    Krzakowski, M
    Roszkowski, K
    Ramlau, R
    Slominski, JM
    Szczesna, A
    Krawczyk, K
    Mozejko-Pastewka, B
    Lis, J
    Miracki, K
    LUNG CANCER, 2002, 35 (01) : 73 - 79
  • [30] Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
    Gatzemeier, U
    Shepherd, FA
    LeChevalier, T
    Weynants, P
    Cottier, B
    Groen, HJM
    Rosso, R
    Mattson, K
    CortesFunes, H
    Tonato, M
    Burkes, RL
    Gottfried, M
    Voi, M
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (02) : 243 - 248
12345